|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$26.19 |
$26.67 |
$25.74 |
$26.10 |
375.20K | 04/23/2024 |
$26.24 |
$27.09 |
$26.19 |
$26.81 |
497.20K | 04/24/2024 |
$26.65 |
$26.77 |
$25.78 |
$25.90 |
359.40K | 04/25/2024 |
$25.70 |
$26.00 |
$25.33 |
$25.50 |
305.80K | 04/26/2024 |
$25.34 |
$26.37 |
$25.33 |
$26.33 |
304.60K |
|
Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and iovera°®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve. | |
|
Pacira BioSciences (PCRX) has the following price history information. Looking back at PCRX historical stock prices for the last five trading days, on April 22, 2024, PCRX opened at $26.19, traded as high as $26.67 and as low as $25.74, and closed at $26.10. Trading volume was a total of 375.20K shares. On April 23, 2024, PCRX opened at $26.24, traded as high as $27.09 and as low as $26.19, and closed at $26.81. Trading volume was a total of 497.20K shares. On April 24, 2024, PCRX opened at $26.65, traded as high as $26.77 and as low as $25.78, and closed at $25.90. Trading volume was a total of 359.40K shares. On April 25, 2024, PCRX opened at $25.70, traded as high as $26.00 and as low as $25.33, and closed at $25.50. Trading volume was a total of 305.80K shares. On April 26, 2024, PCRX opened at $25.34, traded as high as $26.37 and as low as $25.33, and closed at $26.33. Trading volume was a total of 304.60K shares.
PCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pacira BioSciences shares, starting with a $10,000 purchase of PCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$67.01 |
|
End price/share: |
$26.33 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-60.71% |
|
Average Annual Total Return: |
-8.92% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,928.53 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $26.10 | 04/23/2024 | $26.81 | 04/24/2024 | $25.90 | 04/25/2024 | $25.50 | 04/26/2024 | $26.33 |
|
|